MindWalk Holdings Corp. (HYFT) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−5.6x

Market Cap

$62.02M

MomentumView details →

1D Return

−0.75%

YTD Return

−28.02%

RSI (14)

44.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−5.6x

Market Cap

$62.02M

RSI (14)

44.4

MomentumView details →

1D Return

−0.75%

YTD Return

−28.02%

ProfitabilityView details →

Gross Margin

58.79%

Net Margin

−89.63%

EBITDA Margin

−90.26%

ROE (TTM)

−118.09%

ROA (TTM)

−64.91%

Asset Turnover

0.80x

GrowthView details →

Revenue YoY

−15.87%

EPS YoY

+69.05%

FCF YoY

−79.18%

Revenue CAGR 3Y

−9.50%

EPS CAGR 3Y

+66.67%

EBITDA YoY

+54.11%

EarningsView details →

EPS (Actual)

−$0.06

EPS Surprise

−51.25%

Beats (12Q)

2/12

Next Q EPS Est

−$0.05

Avg Surprise (4Q)

−131.56%

Rev Surprise

−7.99%

Capital & dividendView details →

Debt/Equity

0.30x

Current Ratio

2.80x

Quick Ratio

2.72x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

15.45M

Net Income (TTM)

−13.85M

Op. CF (TTM)

−12.51M

Latest newsMore news →

MindWalk Holdings Corp. reported its fiscal 2026 financial results, with revenue up 46% year over year and net loss narrowing by more than half.44d ago

MindWalk Holdings Corp. launched ReefIQ, a biological context layer for AI drug discovery and biologics development.86d ago

Similar companies

Alps Group IncALPS Elicio Therapeutics, Inc.ELTX eXoZymes, Inc.EXOZ Cassava Sciences, Inc.SAVA Fortress Biotech, Inc.FBIOP MiNK Therapeutics, Inc.INKT Find similar companies →

Latest newsMore news →

MindWalk Holdings Corp. reported its fiscal 2026 financial results, with revenue up 46% year over year and net loss narrowing by more than half.44d ago MindWalk Holdings Corp. launched ReefIQ, a biological context layer for AI drug discovery and biologics development.86d ago